Table.
Age of patient in years, reported race, rate of ectopic rupture at presentation, unstable at presentation (heart rate >100 bpm, systolic blood pressure <90 mmHg, or documentation of instability), rate of methotrexate failure after treatment, rate of live ectopic at presentation, β-hCG levels for visualized ectopic, β-hCG levels for ruptured vs non-ruptured ectopic, and greatest diameter of visualized ectopic.
| Variable assessed | Findings |
|---|---|
| Age (Years) | 29.39 (SD 4.42) |
| Race (May include more than one) | |
| White | 51.8% |
| Black | 40.8% |
| Asian | 3.6% |
| American Indian/Native American | 0.6% |
| No response | 2.7% |
| Ruptured at presentation | 22.9% |
| Unstable at presentation | 14.4% |
| Methotrexate failure rate | |
| Single dose | 14.7% |
| Multi dose | 36.9% |
| Live ectopic at presentation | 9.1% |
| β-hCG levels (mIU/mL) | |
| Ruptured | 7,005 (SD 8,949) |
| Non-ruptured | 7,609 (SD 8,773) |
| T-test | P = 0.51 |
| β-hCG for visualized ectopic pregnancy (mIU/mL; n = 456) | |
| Mean | 4,964 (SD 12,217) |
| Median | 1,209 |
| Greatest diameter of visualized ectopic pregnancy (mm; n = 456) | |
| Mean | 24 (SD 14.3) |
| Median | 21 |
β-hCG, beta-human chorionic gonadotropin; mlU/ML, milli-international units per milliliter; mm, millimeter.